ERA 2025: Immune Profiling of Checkpoint Inhibitor-Induced Nephritis Reveals Distinct Subtypes with Prognostic Value
Presented at ERA 2025, this multicentre study identifies three immune subtypes of checkpoint inhibitor–induced nephritis, linking them to clinical outcomes and treatment responses.